Sort
48,018 grants matching “immunotherapy”
Development of a Theranostic Immunotherapy for Systemic Amyloidosis
$425,568Jonathan S Wall · University Of Tennessee Health Sci Ctr · R01 · FY2024 · DK
Role of tumor microenvironment-derived cholesterol in CD8+ T-cell exhaustion
$425,512Qing Yi · Methodist Hospital Research Institute · R01 · FY2021 · CA
Role of tumor microenvironment-derived cholesterol in CD8+ T-cell exhaustion
$425,512Qing Yi · Methodist Hospital Research Institute · R01 · FY2019 · CA
Role of tumor microenvironment-derived cholesterol in CD8+ T-cell exhaustion
$425,512Qing Yi · Methodist Hospital Research Institute · R01 · FY2020 · CA
The Role of Cell-Specific PD-L1 in cardiac pathophysiology post Ischemic Injury and Cancer
$425,505Tousif Sultan · Louisiana State Univ Hsc Shreveport · R01 · FY2025 · HL
Immunotherapy of low grade lymphoid malignancies
$425,494Adrian U Wiestner · National Heart, Lung, And Blood Institute · ZIA · FY2014 · HL
S100A4 mediated immune suppression in GBM
$425,493Kyuson Yun · Methodist Hospital Research Institute · R01 · FY2024 · NS
Influences of HLA Class I Polymorphisms on immune responses
$425,458Malini Raghavan · University Of Michigan At Ann Arbor · R01 · FY2014 · AI
Induction and signature of pathogenic T cells in allergy
$425,455Erik Wambre · Benaroya Research Inst At Virginia Mason · R01 · FY2018 · AI
Induction and signature of pathogenic T cells in allergy
$425,455Erik Wambre · Benaroya Research Inst At Virginia Mason · R01 · FY2016 · AI
Induction and signature of pathogenic T cells in allergy
$425,455Erik Wambre · Benaroya Research Inst At Virginia Mason · R01 · FY2014 · AI
Induction and signature of pathogenic T cells in allergy
$425,455Erik Wambre · Benaroya Research Inst At Virginia Mason · R01 · FY2015 · AI
Induction and signature of pathogenic T cells in allergy
$425,455Erik Wambre · Benaroya Research Inst At Virginia Mason · R01 · FY2017 · AI
Human Anti-Macaque CCR5 Mabs for Passive Immunotherapy
$425,370Dana-Farber Cancer Institute · R01 · FY2005 · AI
Human Anti-Macaque CCR5 Mabs for Passive Immunotherapy
$425,370Dana-Farber Cancer Institute · R01 · FY2004 · AI
Dual-pronged nano-drug delivery using plant virus-like particles.
$425,350Nicole Franziska Steinmetz · University Of California, San Diego · R01 · FY2020 · CA
PROJECT 2: NF1-associated Glioblastoma
$425,323Luis F Parada · Indiana University Indianapolis · U54 · FY2024 · CA
Rare Central Nervous System Cancers Initiative
$425,301Mark Gilbert · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Translational Immunology
$425,301Mark Gilbert · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Pathogenesis of microbial anterior eye diseases
$425,276Gerald B Pier · Brigham And Women'S Hospital · R01 · FY2018 · EY
Pathogenesis of microbial anterior eye diseases
$425,276Gerald B Pier · Brigham And Women'S Hospital · R01 · FY2017 · EY
Analysis and Modulation of Virus-Host Interaction in Animal Models
$425,259Barbara Rehermann · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2011 · DK
How IL-10R blockade can resolve persistent viral infections
$425,250Matthias G. Von Herrath · La Jolla Institute For Immunology · R01 · FY2007 · AI
Modulation of Mcl-1 for Treatment of Lung Cancer
$425,230Xingming Deng · Emory University · R01 · FY2023 · CA
Modulation of Mcl-1 for Treatment of Lung Cancer
$425,225Xingming Deng · Emory University · R01 · FY2022 · CA